The authors concluded that high levels of aberrant methylation at CpG island methylator phenotype-related markers in MSH2-methylated tumors highlights the possibility that MSH2 is a target which is susceptible to aberrant methylation in Lynch syndrome. This evidence concerns the gene MSH2 and Lynch syndrome.